Assignee
REGENERX BIOPHARMACEUTICALS INC
US·2 granted patents·5 pending applications·1 citations·filing 2016–2021
Top patents by PatentIndex Score
7 records- 0173US9585941B2Eye drop formulationREGENERX BIOPHARMACEUTICALS INC·Filed 2016·Granted Mar 7, 2017·1 cites·10 claims
- 0263US10004785B2LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilizedREGENERX BIOPHARMACEUTICALS INC·Filed 2017·Granted Jun 26, 2018·0 cites·15 claims
- 0358US2017128540A1Eye drop formulationREGENERX BIOPHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 0457US2017326207A1Thymosin Beta 4 Promotes Wound RepairREGENERX BIOPHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 0556US2016287673A1Compositions and methods for treating corneal epithelial woundREGENERX BIOPHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 0647US2023190878A1Beta thymosin peptides for treating viral infectionsREGENERX BIOPHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0745US2022241378A1Compositions and methods for treatment of chronic granulomatous diseaseREGENERX BIOPHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when REGENERX BIOPHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →